Citigroup Inc Horizon Therapeutics Public LTD CO Transaction History

Citigroup Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$98.98 - $115.74 $11.1 Million - $13 Million	111,940 Added 46.99%	350,151 $40.5 Million
Q2 2023 Aug 10, 2023	SELL	$96.34 - $112.38 $1.02 Million - $1.19 Million	-10,581 Reduced 4.25%	238,211 $24.5 Million
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $1.26 Million - $1.33 Million	11,698 Added 4.93%	248,792 $27.2 Million
Q4 2022 Feb 09, 2023	SELL	$62.39 - $113.8 $2.6 Million - $4.75 Million	-41,720 Reduced 14.96%	237,094 $27 Million
Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $4.39 Million - $6.31 Million	74,554 Added 36.5%	278,814 $17.3 Million

Q2 2022 Aug 10, 2022	BUY	$79.4 - $116.36 $7.11 Million - $10.4 Million	89,603 Added 78.15%	204,260 $16.3 Million
Q1 2022 May 12, 2022	SELL	$86.42 - $109.81 $458,976 - $583,200	-5,311 Reduced 4.43%	114,657 $12.1 Million
Q4 2021 Feb 10, 2022	SELL	$98.56 - $119.91 $26.4 Million - $32.1 Million	-267,385 Reduced 69.03%	119,968 $12.9 Million
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $35.6 Million - $42.8 Million	387,353 New	387,353 $42.4 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.